At a glance
- Originator Fujisawa
- Class Antiallergics; Antiasthmatics; Small molecules
- Mechanism of Action Histamine receptor antagonists; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Urticaria
Most Recent Events
- 10 Nov 2000 No-Development-Reported for Allergic rhinitis in Japan (PO)
- 10 Nov 2000 No-Development-Reported for Asthma in Japan (PO)
- 10 Nov 2000 No-Development-Reported for Urticaria in Japan (PO)